anmelden
SLI
2.144,50
PKT
+7,51
PKT
+0,35
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.01.20 | UBS Hold | Deutsche Bank AG | |
| 21.01.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 21.01.20 | UBS Neutral | Goldman Sachs Group Inc. | |
| 21.01.20 | Swiss Re Sector Perform | RBC Capital Markets | |
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.01.20 | Holcim overweight | Barclays Capital | |
| 20.01.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.01.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 20.01.20 | UBS Equal weight | Barclays Capital | |
| 20.01.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 17.01.20 | UBS Outperform | Credit Suisse Group | |
| 17.01.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 17.01.20 | UBS Buy | UBS AG | |
| 17.01.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 16.01.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 16.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.01.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 16.01.20 | Novartis Underweight | Barclays Capital | |
| 16.01.20 | Roche overweight | Barclays Capital | |
| 16.01.20 | Roche Neutral | Credit Suisse Group | |
| 16.01.20 | Novartis Neutral | Credit Suisse Group | |
| 15.01.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 15.01.20 | UBS buy | Kepler Cheuvreux | |
| 15.01.20 | Nestlé Underperform | Credit Suisse Group | |
| 15.01.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 14.01.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 14.01.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 13.01.20 | Givaudan Underperform | Bernstein Research | |
| 13.01.20 | UBS overweight | JP Morgan Chase & Co. | |
| 10.01.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 10.01.20 | Roche buy | UBS AG | |
| 10.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 10.01.20 | Nestlé buy | UBS AG | |
| 09.01.20 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 09.01.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 09.01.20 | Roche buy | Deutsche Bank AG | |
| 09.01.20 | Novartis Hold | Deutsche Bank AG | |
| 08.01.20 | Holcim overweight | Morgan Stanley | |
| 08.01.20 | UBS neutral | RBC Capital Markets |